BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 19295333)

  • 1. Successful integration of tuberculosis and HIV treatment in rural South Africa: the Sizonq'oba study.
    Gandhi NR; Moll AP; Lalloo U; Pawinski R; Zeller K; Moodley P; Meyer E; Friedland G;
    J Acquir Immune Defic Syndr; 2009 Jan; 50(1):37-43. PubMed ID: 19295333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care.
    Brust JC; Shah NS; Scott M; Chaiyachati K; Lygizos M; van der Merwe TL; Bamber S; Radebe Z; Loveday M; Moll AP; Margot B; Lalloo UG; Friedland GH; Gandhi NR
    Int J Tuberc Lung Dis; 2012 Aug; 16(8):998-1004. PubMed ID: 22668560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Effectiveness of Initiating Antiretroviral Therapy at Different Points in TB Treatment in HIV-TB Coinfected Ambulatory Patients in South Africa.
    Naidoo K; Grobler AC; Deghaye N; Reddy T; Gengiah S; Gray A; Abdool Karim S
    J Acquir Immune Defic Syndr; 2015 Aug; 69(5):576-84. PubMed ID: 26167618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence in the treatment of patients with extensively drug-resistant tuberculosis and HIV in South Africa: a prospective cohort study.
    OʼDonnell MR; Wolf A; Werner L; Horsburgh CR; Padayatchi N
    J Acquir Immune Defic Syndr; 2014 Sep; 67(1):22-9. PubMed ID: 24872138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Markov model for the effects of virological failure on HIV/AIDS progression in tuberculosis co-infected patients receiving antiretroviral therapy in a rural clinic in northern South Africa.
    Shoko C; Chikobvu D; Bessong PO
    S Afr Med J; 2020 Mar; 110(4):313-319. PubMed ID: 32657744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful Tuberculosis Treatment Outcomes among HIV/TB Coinfected Patients Down-Referred from a District Hospital to Primary Health Clinics in Rural South Africa.
    Jacobson KB; Moll AP; Friedland GH; Shenoi SV
    PLoS One; 2015; 10(5):e0127024. PubMed ID: 25993636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Antiretroviral Therapy on Treatment Outcomes in a Prospective Study of Extensively Drug-Resistant Tuberculosis (XDR-TB) HIV Coinfection Treatment in KwaZulu-Natal, South Africa.
    Yuengling KA; Padayatchi N; Wolf A; Mathema B; Brown T; Horsburgh CR; OʼDonnell MR
    J Acquir Immune Defic Syndr; 2018 Dec; 79(4):474-480. PubMed ID: 30212394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of HIV status and antiretroviral treatment on treatment outcomes of tuberculosis patients in a rural primary healthcare clinic in South Africa.
    Nyasulu PS; Ngasama E; Tamuzi JL; Sigwadhi LN; Ozougwu LU; Nhandara RBC; Ayele BT; Umanah T; Ncayiyana J
    PLoS One; 2022; 17(10):e0274549. PubMed ID: 36223365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addressing challenges in scaling up TB and HIV treatment integration in rural primary healthcare clinics in South Africa (SUTHI): a cluster randomized controlled trial protocol.
    Naidoo K; Gengiah S; Yende-Zuma N; Padayatchi N; Barker P; Nunn A; Subrayen P; Abdool Karim SS
    Implement Sci; 2017 Nov; 12(1):129. PubMed ID: 29132380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of ART on TB case fatality stratified by CD4 count for HIV-positive TB patients in Cape Town, South Africa (2009-2011).
    Kaplan R; Caldwell J; Middelkoop K; Bekker LG; Wood R
    J Acquir Immune Defic Syndr; 2014 Aug; 66(5):487-94. PubMed ID: 24820105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration and task shifting for TB/HIV care and treatment in highly resource-scarce settings: one size may not fit all.
    Van Rie A; Patel MR; Nana M; Vanden Driessche K; Tabala M; Yotebieng M; Behets F
    J Acquir Immune Defic Syndr; 2014 Mar; 65(3):e110-7. PubMed ID: 24091692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High rates of tuberculosis in patients accessing HAART in rural South Africa.
    Naidoo K; Karim QA; Bhushan A; Naidoo K; Yende-Zuma N; McHunu PK; Frohlich J; Karim F; Upfold M; Kocheleff P; Abdool Karim SS
    J Acquir Immune Defic Syndr; 2014 Apr; 65(4):438-46. PubMed ID: 24256629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved Survival and Cure Rates With Concurrent Treatment for Multidrug-Resistant Tuberculosis-Human Immunodeficiency Virus Coinfection in South Africa.
    Brust JCM; Shah NS; Mlisana K; Moodley P; Allana S; Campbell A; Johnson BA; Master I; Mthiyane T; Lachman S; Larkan LM; Ning Y; Malik A; Smith JP; Gandhi NR
    Clin Infect Dis; 2018 Apr; 66(8):1246-1253. PubMed ID: 29293906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved early results for patients with extensively drug-resistant tuberculosis and HIV in South Africa.
    O'Donnell MR; Padayatchi N; Master I; Osburn G; Horsburgh CR
    Int J Tuberc Lung Dis; 2009 Jul; 13(7):855-61. PubMed ID: 19555535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcomes of patients co-infected with HIV and tuberculosis who received a nevirapine-based antiretroviral regimen: a four-year prospective study.
    Manosuthi W; Tantanathip P; Chimsuntorn S; Eampokarap B; Thongyen S; Nilkamhang S; Sungkanuparph S
    Int J Infect Dis; 2010 Nov; 14(11):e1013-7. PubMed ID: 20880733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study of once-daily antiretroviral therapy integrated with tuberculosis directly observed therapy in a resource-limited setting.
    Jack C; Lalloo U; Karim QA; Karim SA; El-Sadr W; Cassol S; Friedland G
    J Acquir Immune Defic Syndr; 2004 Aug; 36(4):929-34. PubMed ID: 15220699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tuberculosis on the kinetics of CD4(+) T cell count among HIV-infected patients who initiated antiretroviral therapy early after tuberculosis treatment.
    Ku NS; Oh JO; Shin SY; Kim SB; Kim HW; Jeong SJ; Han SH; Song YG; Kim JM; Choi JY
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):226-30. PubMed ID: 22881387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential adherence to antiretroviral therapy over tuberculosis treatment: a qualitative study of drug-resistant TB/HIV co-infected patients in South Africa.
    Daftary A; Padayatchi N; O'Donnell M
    Glob Public Health; 2014; 9(9):1107-16. PubMed ID: 25035943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating Community-Based Interventions to Reverse the Convergent TB/HIV Epidemics in Rural South Africa.
    Gilbert JA; Long EF; Brooks RP; Friedland GH; Moll AP; Townsend JP; Galvani AP; Shenoi SV
    PLoS One; 2015; 10(5):e0126267. PubMed ID: 25938501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse events in an integrated home-based treatment program for MDR-TB and HIV in KwaZulu-Natal, South Africa.
    Brust JC; Shah NS; van der Merwe TL; Bamber S; Ning Y; Heo M; Moll AP; Loveday M; Lalloo UG; Friedland GH; Gandhi NR
    J Acquir Immune Defic Syndr; 2013 Apr; 62(4):436-40. PubMed ID: 23254152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.